Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
Normalizing ALT liver enzyme levels is associated with positive long-term outcomes.
So found a study of more than 1,500 people treated for hep C, including almost 600 people with compensated advanced chronic liver disease.
Smoking cessation, a healthy diet, exercise and weight loss could dramatically reduce new liver cancer cases and liver disease deaths.
Experimental therapy led to weight loss and improved biomarkers of liver health.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
The treatment improved ALT liver enzymes, fat accumulation in the liver, insulin resistance and blood lipid levels.
This includes people who use drugs, those with psychiatric disorders and those with a history of alcohol use.
A pooled analysis of numerous clinical trials and real-world studies reached this conclusion.
New cases of all three viruses have declined in the city over the past decade.
Nonetheless, half of people with NAFLD were able to reach a 5% weight loss goal using a very low energy diet.
The new, minimally invasive outpatient procedure targets a part of the small intestine that plays a key role in diabetes.
Well-tolerated insulin sensitizer may play a role in the treatment of fatty liver disease.
Consistent use of medication-assisted treatment for opioid use disorder can apparently reduce this risk.
Women with a history of the malignancy also survive longer than men after receiving a liver transplant.
A Rhode Island study found that testing for hepatitis C among people on probation is likely a good way to find undiagnosed individuals.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.